BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26995027)

  • 1. Identification of mutated driver pathways in cancer using a multi-objective optimization model.
    Zheng CH; Yang W; Chong YW; Xia JF
    Comput Biol Med; 2016 May; 72():22-9. PubMed ID: 26995027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of driver pathways in cancer based on combinatorial patterns of somatic gene mutations.
    Li HT; Zhang J; Xia J; Zheng CH
    Neoplasma; 2016; 63(1):57-63. PubMed ID: 26639234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulated annealing based algorithm for identifying mutated driver pathways in cancer.
    Li HT; Zhang YL; Zheng CH; Wang HQ
    Biomed Res Int; 2014; 2014():375980. PubMed ID: 24982873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient methods for identifying mutated driver pathways in cancer.
    Zhao J; Zhang S; Wu LY; Zhang XS
    Bioinformatics; 2012 Nov; 28(22):2940-7. PubMed ID: 22982574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying overlapping mutated driver pathways by constructing gene networks in cancer.
    Wu H; Gao L; Li F; Song F; Yang X; Kasabov N
    BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S3. PubMed ID: 25859819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying mutated driver pathways in cancer by integrating multi-omics data.
    Wu J; Cai Q; Wang J; Liao Y
    Comput Biol Chem; 2019 Jun; 80():159-167. PubMed ID: 30959272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo discovery of mutated driver pathways in cancer.
    Vandin F; Upfal E; Raphael BJ
    Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
    Zhang J; Zhang S; Wang Y; Zhang XS
    BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A NOVEL AND EFFICIENT ALGORITHM FOR DE NOVO DISCOVERY OF MUTATED DRIVER PATHWAYS IN CANCER.
    Liu B; Wu C; Shen X; Pan W
    Ann Appl Stat; 2017 Sep; 11(3):1481-1512. PubMed ID: 29479394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Integrated Framework for Identifying Mutated Driver Pathway and Cancer Progression.
    Zhang W; Wang SL
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(2):455-464. PubMed ID: 29990286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of driver pathways using mutated gene network in cancer.
    Li F; Gao L; Ma X; Yang X
    Mol Biosyst; 2016 Jun; 12(7):2135-41. PubMed ID: 27118146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms.
    Zhang J; Zhang S
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(3):988-998. PubMed ID: 28113329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of mutated subnetworks associated with clinical data in cancer.
    Vandin F; Clay P; Upfal E; Raphael BJ
    Pac Symp Biocomput; 2012; ():55-66. PubMed ID: 22174262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network.
    Wei PJ; Zhang D; Xia J; Zheng CH
    BMC Bioinformatics; 2016 Dec; 17(Suppl 17):467. PubMed ID: 28155630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous identification of multiple driver pathways in cancer.
    Leiserson MD; Blokh D; Sharan R; Raphael BJ
    PLoS Comput Biol; 2013; 9(5):e1003054. PubMed ID: 23717195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Protein-Protein Interaction Networks and Somatic Mutation Data to Detect Driver Modules in Pan-Cancer.
    Wu H; Chen Z; Wu Y; Zhang H; Liu Q
    Interdiscip Sci; 2022 Mar; 14(1):151-167. PubMed ID: 34491536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A latent variable model for evaluating mutual exclusivity and co-occurrence between driver mutations in cancer.
    Shuaibi A; Chitra U; Raphael BJ
    bioRxiv; 2024 Apr; ():. PubMed ID: 38712136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.
    Zhang J; Liu J; Sun J; Chen C; Foltz G; Lin B
    Brief Bioinform; 2014 Mar; 15(2):244-55. PubMed ID: 23818492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Driver Modules with Rarely Mutated Genes in Cancers.
    Li F; Gao L; Wang B
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(2):390-401. PubMed ID: 29994261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Driver Missense Mutation Identification Using Feature Selection and Model Fusion.
    Soliman AT; Meng T; Chen SC; Iyengar SS; Iyengar P; Yordy J; Shyu ML
    J Comput Biol; 2015 Dec; 22(12):1075-85. PubMed ID: 26402258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.